Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59189665Aexternal-prioritypatent/JPS6168329A/ja
Priority claimed from JP18966684Aexternal-prioritypatent/JPS6167539A/ja
Priority claimed from JP18966784Aexternal-prioritypatent/JPS6168302A/ja
Priority claimed from JP59271411Aexternal-prioritypatent/JPS61148187A/ja
Application filed by Chugai Pharmaceutical Co LtdfiledCriticalChugai Pharmaceutical Co Ltd
Application grantedgrantedCritical
Publication of CA1256115ApublicationCriticalpatent/CA1256115A/fr
Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine
Platinum (IV)-diamine complex, method for the preparation of this compound, preparation with an anti-tumour action, which contains at least one platinum compound, and shaped preparation with an anti-tumour action